Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 6, keine Gesamtzahl für „Simponi“
Suchtreffer
Begriffe & Kennungen
Simponi · 4.8 · Cases reported in clinical studies in asthma In an exploratory clinical study, patients with severe persistent
Eintrag öffnenSimponi · 4.8 · Cases reported in clinical studies in asthma In an exploratory clinical study, patients with severe persistent
Eintrag öffnenSimponi · 4.8 · Cases reported in clinical studies in asthma In an exploratory clinical study, patients with severe persistent
Eintrag öffnenSimponi · 4.8 · Description of selected adverse reactions
Eintrag öffnenSimponi · 4.8 · Description of selected adverse reactions
Eintrag öffnenSimponi · 4.8 · Description of selected adverse reactions
Eintrag öffnenSimponi · 4.8 · Description of selected adverse reactions
Eintrag öffnenSimponi · 4.8 · Description of selected adverse reactions
Eintrag öffnenSimponi · 4.8 · During the placebo-controlled portion of the study, the incidence (95% CI) of all malignancies per 100 subject
Eintrag öffnenSimponi · 4.8 · During the placebo-controlled portion of the study, the incidence (95% CI) of all malignancies per 100 subject
Eintrag öffnenSimponi · 4.8 · During the placebo-controlled portion of the study, the incidence (95% CI) of all malignancies per 100 subject
Eintrag öffnenSimponi · 4.8 · During the placebo-controlled portion of the study, the incidence (95% CI) of all malignancies per 100 subject
Eintrag öffnenSimponi · 4.8 · During the placebo-controlled portion of the study, the incidence (95% CI) of all malignancies per 100 subject
Eintrag öffnenSimponi · 4.8 · In controlled Phase IIb and/or III trials in RA, PsA, AS, nr-Axial SpA, severe persistent asthma, and Phase II
Eintrag öffnenSimponi · 4.8 · In controlled Phase IIb and/or III trials in RA, PsA, AS, nr-Axial SpA, severe persistent asthma, and Phase II
Eintrag öffnenSimponi · 4.8 · In controlled Phase IIb and/or III trials in RA, PsA, AS, nr-Axial SpA, severe persistent asthma, and Phase II
Eintrag öffnenSimponi · 4.8 · In controlled Phase IIb and/or III trials in RA, PsA, AS, nr-Axial SpA, severe persistent asthma, and Phase II
Eintrag öffnenSimponi · 4.8 · In controlled Phase IIb and/or III trials in RA, PsA, AS, nr-Axial SpA, severe persistent asthma, and Phase II
Eintrag öffnenSimponi · 4.8 · In the controlled and uncontrolled period of pivotal trials with a median follow-up of up to 3 years, malignan
Eintrag öffnenSimponi · 4.8 · In the controlled and uncontrolled period of pivotal trials with a median follow-up of up to 3 years, malignan
Eintrag öffnen